eShowcase: ClinPhone Compact
Service Configures Ready-Made Solution for Randomization and Trial Supply Management
Service Configures Ready-Made Solution for Randomization and Trial Supply Management
ClinPhone (Nottingham, UK) announces its ClinPhone Compact, a new service created to meet the needs of many conventional study designs by offering a ready-made application for Interactive Voice Response and Interactive Web Response deployment.
eShowcase: ClinPhone Compact
The new service is hosted by ClinPhone and utilizes its existing infrastructure offerings of 24/7 global support, unlimited language capabilities, and an extensive toll-free network of 82 countries.
ClinPhone Compact allows pharmaceutical and biotechnology sponsors to perform central randomization, emergency code break, medication dispensation, and site and depot supplies management combined with real-time study progress reporting. Because the solution is ready-made, it minimizes the need for study-specific customization, including programming, testing, and validation. As such, this can lower sponsors' costs and accelerate timelines.
ClinPhone plc, +44 (0)115 9557555, www.clinphone.com
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Phase III SELECT-GCA Trial Results Lead to FDA Approval of Rinvoq for Giant Cell Arteritis
April 30th 2025Rinvoq (upadacitinib) becomes the first oral JAK inhibitor approved by the FDA for the treatment of giant cell arteritis in adults, following robust data from the Phase III SELECT-GCA trial demonstrating its efficacy in achieving sustained remission and reducing glucocorticoid exposure.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
